Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 29,2020
Rectal Cancer Early Screening Kit
On November 9, 2020, the National Medical Products Administration (NMPA) approved the registration application for the innovative three types of medical devices for the colorectal cancer early screening product of Nuohui Health, Chang Weiqing, and made it clear in the intended use that the product is suitable for " Screening of 40-74-year-old people at high risk of colorectal cancer".
More
Rectal Cancer Early Screening Kit
Nov 27,2020
The latest advances in the development of preclinical HIV vaccines
As researchers continue to find effective ways to fight HIV, but there is still no effective and approved preventive vaccine, vaccines are a key means to prevent the spread of HIV disease. There are 38 million people living with AIDS in the world, and many studies are devoted to developing effective methods to prevent theRead more
More
Nov 23,2020
The details of pathological research determine the success or failure of TCR trials
What is TCR? Tissue Cross-Reactivity is an in vitro test that detects the binding of antibody drugs to epitopes on tissues. The purpose is to confirm the binding of the tested antibody to the epitope of the pharmacodynamic target tissue, and to detect whether the antibody binds to the tissue antigen of the non-target site,Read more
More
The details of pathological research determine the success or failure of TCR trials
Nov 23,2020
Melatonin has become the "savior" of COVID-19 patients!
Melatonin is a hormone produced by the pineal gland of the brain. People can also use it as a natural or synthetic supplement to promote sleep. Melatonin plays many roles in the body, but the main role is to maintain the circadian rhythm. For humans, the central biological clock is located in the suprachiasmatic nucleusRead more
More
Melatonin has become the "savior" of COVID-19 patients!
Nov 17,2020
The strategy of chemical modification to reduce the cardiotoxicity of drug hERG
Reduce fat solubility Through QSAR analysis, Levoin et al. pointed out that the lipid solubility (clogP, clogD or polar surface area PSA) and aromaticity of the molecule are closely related to the hERG inhibitory activity. The fat-soluble aromatic ring in the drug molecule has a π-π hydrophobic interaction with the hERG potassium channel. Reducing theRead more
More
The strategy of chemical modification to reduce the cardiotoxicity of drug hERG
Nov 16,2020
Metformin is here again
Among the many hypoglycemic drugs, metformin has been tested for more than 50 years and is the second-generation “star” in hypoglycemic drugs, the first choice for the treatment of “type 2 diabetes” and the entire course, and the first choice for combined treatment of type 2 diabetes. In this way, after the US FDA approvedRead more
More
Nov 12,2020
Exercise Became the "Good Medicine" for Cancer Treatment
Exercise affects almost all tissues of the human body. Scientists have found that physical exercise can reduce the risk of cancer and improve the prognosis of cancer patients. People who keep exercising tend to have a lower incidence of cancer, which is proportional to the frequency and intensity of exercise. The metabolic demands of strenuousRead more
More
Exercise Became the "Good Medicine" for Cancer Treatment
Nov 04,2020
Nature: BATF3 improves T cell memory response and the efficacy of immunotherapy
The basic leucine zipper transcription factor ATF-like 3 (BATF3) plays a key role in the development of conventional type I dendritic cells, and this type of dendritic cells plays a key role in the cross-presentation of pathogens and CD8+ T cell-mediated It is necessary in immune response such as tumor immunity. During the immune responseRead more
More
Nature: BATF3 improves T cell memory response and the efficacy of immunotherapy
Oct 22,2020
Medicine Symposium No. 8-Drug Preclinical Research and Application
Over the years, Medicilon has been actively empowering the upgrading of life sciences and building a platform to promote the integrated development of the biomedical industry. In 2019, starting from the 15th anniversary, a national tour of seminars was launched, and seven pre-clinical research related seminars were successively held. The Medicilon research team shared theRead more
More
Medicine Symposium No. 8-Drug Preclinical Research and Application
Oct 21,2020
International teams join forces to accelerate drug design based on the structure of COVID-19!
SARS-CoV-2 is an enveloped single-stranded RNA virus. The viral RNA produces two polyproteins: pp1a and pp1ab through ribosome frameshift. The polyprotein is processed by the papain-like protease (PL pro), which cuts 3 sites to release the non-structural protein nsp1-3 and a 3C-like protease, also known as the main protease (M pro). Cut at 11 sitesRead more
More
International teams join forces to accelerate drug design based on the structure of COVID-19!
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->